Correction - Biophytis launches a Public Offering of
Share Subscription Warrants (BSA) with an Irreducible Priority
Subscription Period for Existing Shareholders
Paris (France), Cambridge (Etats-Unis), April 21 , 2020, 8:00 a.m. CEST – BIOPHYTIS (Euronext Growth
Paris: ALBPS), today issued a correction of the press release issued on April 7, 2020, in order to
consolidate important information relating to the offer to the public of Share Subscription Warrants
(BSA) with an irreducible priority period for shareholders. This information was included until today in
the Synthetic Information Document (DIS) posted on the Biophytis website on April 7, 2020. However,
under this transaction, the Company was not subject to the publication of a DIS.
Below is the corrected press release:
Paris, (France), Cambridge (Massachusetts, United States), Biophytis SA (Euronext Growth Paris: ALBPS
a clinical-stage biotechnology company specialized in the development of drug candidates for treatment
of aged related diseases, especially neuromuscular diseases, announced on April 7, 2020 the launch of
a public offering of 7,445,123 Share Subscription Warrants (BSA), which could be increased to 7,475,708
BSA, by way of a public offering with an irreducible priority subscription period for existing shareholders,
as well as an extension clause.
Offering price
The subscription price will be €0.06 per BSA for a total amount of €446,707.38 and €448,542.48 if the
extension clause is exercised.
BSA Offering
The proposed issuance of the 7,445,123 BSA, to be subscribed in cash, will be carried out with
shareholders’ preferential subscription rights removed. The Offer will include (i) a priority period for
shareholders on an irreducible basis only, with 3 BSA for every 16 shares held as of April 8, 2020
(operation settled at this date) (rounded to the higher unit if the number of shares is not a multiple of
16) and (ii) an extension clause to increase the issue to 7,475,708 BSA.
Shareholders registered as of April 8, 2020 (operation settled at this date) will benefit from a non-
negotiable and non-transferable subscription priority period, from April 9, 2020 to April 21, 2020
included at 12:00 p.m. (Paris time). As a result, all shares purchased on 7
th and 8th April 2020 will not
benefit from the priority period.
As part of the priority period, the Company's shareholders will be able to subscribe on an irreducible
basis to the extent of their shares in the Company's capital pursuant to the terms set out above. There
are no plans to allow subscriptions on a reducible basis during the priority period.
Unsubscribed BSAs will then be offered first to the Company's employees and executive officers within
the limits of their requests. The Priority Period relates to the initial issuance amount, excluding the